Generic Drug Development CDMO

Explore expert insights on generic drug development CDMO services, covering analytical characterization, impurity profiling, method validation, and regulatory support for ANDA submissions. This category highlights advanced strategies in complex generics, peptide-based drugs, and small molecules, with a focus on meeting global regulatory requirements and accelerating time-to-market through integrated CRO and CDMO solutions.

Key Analytical Challenges in GLP-1 Peptide Drugs and How CDMOs Solve Them

March 19, 2026

Introduction: GLP-1 Peptide Analytical Characterization plays a crucial role in ensuring the safety, efficacy, and regulatory compliance of peptide-based therapeutics. […]

Key Analytical Challenges in GLP-1 Peptide Drugs and How CDMOs Solve Them Read More »

ResolveMass Laboratories Inc.

About us

ResolveMass Laboratories Inc. specializes in mass spectrometry services (Bioanalytical, Biomarker Quantification, Proteomics, Lipidomics, Metabolomics), custom organic synthesis, Custom Polymer Synthesis and controlled drug delivery systems. Located in Montreal, Canada, we provide our services across the world (United States, France, United Kingdom, Japan, Germany, Australia, South Korea, India and around the world.

Home
About us
Services
Products
Learn with us
Contact

Contact Us

Address: 500 Bd Cartier O, Laval, QC, Canada H7V 5B7

Email: info@resolvemass.ca

Phone: +1-306-705-7145

Disclaimer

Terms and Conditions

Scroll to Top

Review Your Cart

Discount

Add Coupon Code

Subtotal

Total Installment Payments

Bundle Discount

Checkout